In patients with ITP, Intravenous immunoglobulin (IVIG) increases the platelet count by decreasing the destruction of platelets in your spleen. IVIG may also work in patients with or without a spleen by binding to and neutralizing the antibodies responsible for destroying platelets.
What is the mechanism of action of IVIG?
The effects of exogenous antibodies on B-cells have been well studied; IVIg is thought to down-regulate antibody production by B-cells, interfere with B-cell proliferation via a blockade of cell surface receptors and prevent the activation of certain subtypes of B-cell.
How does IVIG help platelets?
Platelets are a type of blood cells that help keep the body from bleeding too much. Antibodies are a type of protein. IVIG contains antibodies that bind to the cells in the spleen, which keeps these cells from destroying the platelets. More platelets stay in the blood, and your child’s platelet count goes up.
What is the role of IVIG?
IVIg gives you antibodies that your body is not making on its own so you can fight infections. In autoimmune diseases like lupus, the treatment may help your body raise low red-blood-cell counts.
How does immunoglobulin help ITP?
IVIG temporarily increases the platelet count in about 80 percent of ITP patients. The duration of the response varies and the treatment can be repeated when the platelet count drops. IVIg does not work very well for those ITP patients who have anti-GPIbalpha antibodies on their platelets.
Can IVIG cause ITP?
Conclusions: This is the first reported case of thrombocytopenia as a possible adverse effect of IVIG.
What is the action of immunoglobulin?
The mechanisms of action of Ig not only involve the blockade of Fc receptors of phagocytes, but also control complement pathways, idiotype-anti-idiotype dimer formation, blockage of superantigen binding to T cells, inhibition of dendritic cells and stimulation of regulatory T cells (Tregs).
What is the MOA of IVIg in treatment of GBS?
Therapeutic IVIg is capable of neutralizing neuromuscular blocking antibodies in GBS by a dose-dependent, antibody-mediated mechanism. This may, in part, explain its therapeutic efficacy.
Do you give platelets in ITP?
Key Points. Platelet transfusions are frequently administered to hospitalized patients with platelet consumptive/destructive disorders such as TTP, HIT, and ITP. Platelet transfusions are associated with higher odds of arterial thrombosis and mortality among TTP and HIT patients.
Is IVIG monoclonal antibodies?
Immunoglobulin-based therapies, such as monoclonal antibodies and intravenous immuno- globulin (IVIg), have emerged as a major force in providing safe and effective long-term therapy for patients who do not respond to conventional anti-inflammatory drugs (Box 1 and Figure 1).
Is IVIG an immunosuppressant?
Does IVIG cause immunosuppression? Although the data classifying IVIG therapies as immunosuppressing agents is not conclusive, studies do show IVIG treatments have been found to help reduce symptoms of autoimmune diseases that exhibit excessive inflammation of the body.
Does IVIg treat ITP?
Originally found to ameliorate ITP in pediatric patients, IVIg is now used to treat adult patients with acute and chronic ITP and has become a first-line therapy for this autoimmune disease. Treatment in adult ITP usually consists of high-doses of IVIg, usually 1–2 g/kg given as one bolus dose or over 4 to 5 days.
What is the role of IVIG in idiopathic thrombopenic purpura (ITP)?
The therapeutic benefit of IVIg in Wiskott–Aldrich syndrome led, in a serendipitous manner, to its further usage in idiopathic thrombopenic purpura (ITP). The successful result in ITP in turn opened the flood gates for IVIg therapy. This resulted in widespread application of IVIg in a variety of autoimmune and inflammatory disorders.
How does high-dose IVIG therapy work?
High-dose IVIG therapy, in contrast, exerts its action through its non-specific interactions with various immune molecules and cells, as seen above. Hyperimmune IgG action is instant and leads to efficient clearance of specific pathogenic microorganisms or toxins mediating the disease.
How does intravenous immunoglobulin work in autoimmune and inflammatory diseases?
Intriguingly, despite its use for over three decades in autoimmune and inflammatory diseases, the precise mechanisms underlying the clinical benefit in each of these pathologies have not been illustrated. The regulatory effects of IVIg are mediated by mutually non-exclusive complex mechanisms of action.
Is IVIG effective in autoimmune and inflammatory diseases?
This resulted in widespread application of IVIg in a variety of autoimmune and inflammatory disorders. Intriguingly, despite its use for over three decades in autoimmune and inflammatory diseases, the precise mechanisms underlying the clinical benefit in each of these pathologies have not been illustrated.
